We’re thrilled to announce a new strategic alliance between ExSyn, Exim-Indis and simABs, a leading EU-based biologics manufacturer known for its patented continuous flow technology in antibody production.
ExSyn and Exim-Indis will now represent simABs in the Indian and the U.S. markets respectively —bringing their innovative, high-quality antibodies to researchers, biotech companies, and healthcare providers.
simAbs: Smart Integrated Manufacturing of ATMP’s and Biologics
simAbs provides the full range of services and support for biologics development and GMP manufacturing, specializing in sustainable biomanufacturing technologies.
For more details, please visit:
https://www.simabs.com/
Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.
The Vibrant World of Wazamba Casino Table of Contents Introduction to Wazamba Casino Games Offered Exciting Promotions Payment Methods Security and Fairness Customer Support Conclusion Introduction to Wazamba Casino Step into the exhilarating realm of wazamba casino, where adventure awaits at every turn! With its unique theme that immerses players in a colorful and vibrant […]
Peppermint (Mentha piperita) is a common herb, also known as a hybrid mint. Its main components are oxygenated monoterpenes: alcohols, esters and ketones. Peppermint oleoresin microencapsulated powder is a white to off-white coloured powder produced from the seeds of the plant. In order to protect and maintain the stability of peppermint oil, microencapsulation is carried out through process optimization using the coacervation technique. This technique helps limit the loss and degradation of flavours and aromas during processing and storage. It offers versatile applications across multiple industries — from food and beverages to pharmaceuticals, cosmetics, and textiles.
Products containing titanium dioxide in the EU are no longer required to carry warnings about cancer risk, after the European Chemicals Agency (Echa) revoked its classification as a suspected carcinogen. The move follows a June 2025 decision by the Court of Justice of the European Union and means that safety data sheets, labelling and packaging requirements for titanium dioxide have been relaxed across industries including paints, pharmaceuticals, cosmetics and food.